These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 31069004)

  • 1. Do tumor cells escape from natural killer cell cytotoxicity by mimicking dendritic cells?
    Wurzer H; Al Absi A; Hoffmann C; Thomas C
    Oncotarget; 2019 Mar; 10(25):2419-2420. PubMed ID: 31069004
    [No Abstract]   [Full Text] [Related]  

  • 2. Activating natural cytotoxicity receptors of natural killer cells in cancer and infection.
    Koch J; Steinle A; Watzl C; Mandelboim O
    Trends Immunol; 2013 Apr; 34(4):182-91. PubMed ID: 23414611
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNA-519a-3p mediates apoptosis resistance in breast cancer cells and their escape from recognition by natural killer cells.
    Breunig C; Pahl J; Küblbeck M; Miller M; Antonelli D; Erdem N; Wirth C; Will R; Bott A; Cerwenka A; Wiemann S
    Cell Death Dis; 2017 Aug; 8(8):e2973. PubMed ID: 28771222
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of B7-1 by Pam 212 squamous cell carcinoma enhances tumor cell interactions with dendritic epidermal cells but does not affect in vivo tumor growth.
    Yeh KY; Chen Z; Nasir A; Ohsuga Y; Takashima A; Lord EM; Gaspari AA
    J Invest Dermatol; 1997 Dec; 109(6):728-33. PubMed ID: 9406812
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Natural killer cells license dendritic cell cross-presentation of B lymphoma cell--associated antigens.
    Dao T; Gomez-Nunez M; Antczak C; Kappel B; Jaggi JS; Korontsvit T; Zakhaleva V; Scheinberg DA
    Clin Cancer Res; 2005 Dec; 11(24 Pt 1):8763-72. PubMed ID: 16361564
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanisms of tumor and viral immune escape from natural killer cell-mediated surveillance.
    Groth A; Klöss S; von Strandmann EP; Koehl U; Koch J
    J Innate Immun; 2011; 3(4):344-54. PubMed ID: 21576922
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Podocalyxin-like protein 1 functions as an immunomodulatory molecule in breast cancer cells.
    Amo L; Tamayo-Orbegozo E; Maruri N; Buqué A; Solaun M; Riñón M; Arrieta A; Larrucea S
    Cancer Lett; 2015 Nov; 368(1):26-35. PubMed ID: 26276714
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Natural killer cell immune escape in acute myeloid leukemia.
    Lion E; Willemen Y; Berneman ZN; Van Tendeloo VF; Smits EL
    Leukemia; 2012 Sep; 26(9):2019-26. PubMed ID: 22446501
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Actin retrograde flow controls natural killer cell response by regulating the conformation state of SHP-1.
    Matalon O; Ben-Shmuel A; Kivelevitz J; Sabag B; Fried S; Joseph N; Noy E; Biber G; Barda-Saad M
    EMBO J; 2018 Mar; 37(5):. PubMed ID: 29449322
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The roles of soluble MICA in immune escape of breast tumor].
    Ye YB; Zhou ZF; Chen Q; Li JY; Chen X; Huang WW
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2008 Sep; 24(9):904-7. PubMed ID: 18782524
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Natural Killer Group 2D Ligand Depletion Reconstitutes Natural Killer Cell Immunosurveillance of Head and Neck Squamous Cell Carcinoma.
    Weil S; Memmer S; Lechner A; Huppert V; Giannattasio A; Becker T; Müller-Runte A; Lampe K; Beutner D; Quaas A; Schubert R; Herrmann E; Steinle A; Koehl U; Walter L; von Bergwelt-Baildon MS; Koch J
    Front Immunol; 2017; 8():387. PubMed ID: 28443091
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immune function of plasmacytoid dendritic cells, natural killer cells, and their crosstalk in HBV infection.
    Golsaz-Shirazi F; Amiri MM; Shokri F
    Rev Med Virol; 2018 Nov; 28(6):e2007. PubMed ID: 30175481
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lung derived surface active material (SAM) inhibits natural killer cell tumor cytotoxicity.
    Baughman RP; Strohofer S
    J Clin Lab Immunol; 1989 Feb; 28(2):51-4. PubMed ID: 2787406
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human natural killer cells: a comprehensive review.
    Sinkovics JG; Horvath JC
    Int J Oncol; 2005 Jul; 27(1):5-47. PubMed ID: 15942642
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Negative regulation of tumor-infiltrating NK cell in clear cell renal cell carcinoma patients through the exosomal pathway.
    Xia Y; Zhang Q; Zhen Q; Zhao Y; Liu N; Li T; Hao Y; Zhang Y; Luo C; Wu X
    Oncotarget; 2017 Jun; 8(23):37783-37795. PubMed ID: 28384121
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes in peripheral T-cell subsets and natural-killer cytotoxicity in relation to colorectal cancer surgery.
    Tartter PI; Martinelli G; Steinberg B; Barron D
    Cancer Detect Prev; 1986; 9(3-4):359-64. PubMed ID: 3488807
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The dual-functional capability of cytokine-induced killer cells and application in tumor immunology.
    Zhang Q; Liu XY; Zhang T; Zhang XF; Zhao L; Long F; Liu ZK; Wang EH
    Hum Immunol; 2015 May; 76(5):385-91. PubMed ID: 25305457
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunoselection of breast and ovarian cancer cells with trastuzumab and natural killer cells: selective escape of CD44high/CD24low/HER2low breast cancer stem cells.
    Reim F; Dombrowski Y; Ritter C; Buttmann M; Häusler S; Ossadnik M; Krockenberger M; Beier D; Beier CP; Dietl J; Becker JC; Hönig A; Wischhusen J
    Cancer Res; 2009 Oct; 69(20):8058-66. PubMed ID: 19826050
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Natural killer cell-mediated immunosurveillance of human cancer.
    Malmberg KJ; Carlsten M; Björklund A; Sohlberg E; Bryceson YT; Ljunggren HG
    Semin Immunol; 2017 Jun; 31():20-29. PubMed ID: 28888619
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Natural killer and dendritic cell contact in lesional atopic dermatitis skin--Malassezia-influenced cell interaction.
    Buentke E; Heffler LC; Wilson JL; Wallin RP; Löfman C; Chambers BJ; Ljunggren HG; Scheynius A
    J Invest Dermatol; 2002 Oct; 119(4):850-7. PubMed ID: 12406330
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.